Bai L, Liu S, Luo B
Beijing Research Institute of Tuberculosis and Thoracic Tumor.
Zhonghua Jie He He Hu Xi Za Zhi. 1995 Jun;18(3):170-2, 191.
The author analysed the effect of surgical therapy in 165 cases with stage III SCLC from 1979 to the end of 1991, and compared with 87 cases of combined therapy and 78 cases in simple operative therapy. The author also makes an observation of cases with pre-operative and (or) post-operative chemo- and radiation therapy. Their over-all 5 year survival rate was 16.6%. Stage among 5 year survival cases in TNM stage. IIIa was 20.4% and no for Stage IIIb. The 5 year survival of combined therapy was 22.8% and that of simple operative group was 7.9%. The result shows that in the Stage III SCLC combined therapy is superior to that of simple operative group. It seems that postoperative radiation and chemotherapy is better than pre-operative in combined therapy group. The author's opinion is that surgical indication of SCLC is limited to stage IIIa.
作者分析了1979年至1991年底165例Ⅲ期小细胞肺癌患者的手术治疗效果，并与87例综合治疗患者和78例单纯手术治疗患者进行了比较。作者还观察了术前和（或）术后进行化疗和放疗的病例。其5年总生存率为16.6%。TNM分期中5年生存病例中Ⅲa期为20.4%，Ⅲb期无。综合治疗组的5年生存率为22.8%，单纯手术组为7.9%。结果表明，在Ⅲ期小细胞肺癌中，综合治疗优于单纯手术组。在综合治疗组中，术后放疗和化疗似乎比术前更好。作者认为，小细胞肺癌的手术适应证仅限于Ⅲa期。
